Molecular_JJ
mechanisms_NNS
of_IN
steroid_NN
action_NN
:_:
a_DT
novel_JJ
type_NN
of_IN
cross-talk_NN
between_IN
glucocorticoids_NNS
and_CC
NF-kappa_NN
B_NN
transcription_NN
factors_NNS
._.

Despite_IN
the_DT
widespread_JJ
use_NN
of_IN
glucocorticoids_NNS
in_IN
the_DT
treatment_NN
of_IN
diseases_NNS
characterized_VBN
by_IN
inflammation_NN
,_,
the_DT
molecular_JJ
mechanism_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
by_IN
which_WDT
these_DT
hormones_NNS
exert_VBP
this_DT
beneficial_JJ
effect_NN
in_IN
patients_NNS
with_IN
asthma_NN
remains_VBZ
to_TO
be_VB
elucidated_VBN
._.

Therefore_RB
,_,
we_PRP
have_VBP
studied_VBN
the_DT
transcriptional_JJ
regulation_NN
of_IN
intercellular_JJ
adhesion_NN
molecule-1_NN
-LRB-_-LRB-
ICAM-1_NN
-RRB-_-RRB-
as_IN
adhesion_NN
molecules_NNS
are_VBP
likely_JJ
to_TO
play_VB
a_DT
causal_JJ
role_NN
in_IN
inflammation_NN
in_IN
promoting_VBG
cell-cell_JJ
and_CC
cell-matrix_JJ
interactions_NNS
._.

We_PRP
observed_VBD
that_IN
in_IN
a_DT
monocytic_JJ
-LRB-_-LRB-
U937_NN
-RRB-_-RRB-
and_CC
a_DT
bronchial_JJ
epithelial_NN
-LRB-_-LRB-
H292_NN
-RRB-_-RRB-
cell-line_JJ
dexamethasone_NN
strongly_RB
suppressed_VBD
basal_JJ
and_CC
induced_JJ
ICAM-1_NN
expression_NN
._.

Subsequent_JJ
analysis_NN
of_IN
the_DT
human_JJ
ICAM-1_NN
promoter_NN
has_VBZ
revealed_VBN
that_IN
both_CC
12-O-tetradecanoylphorbol_NN
13-acetate_NN
-LRB-_-LRB-
TPA_NN
-RRB-_-RRB-
and_CC
tumor_NN
necrosis_NN
factor-alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
upregulate_VBP
ICAM-1_NN
expression_NN
through_IN
the_DT
presence_NN
of_IN
a_DT
nuclear_JJ
factor_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
target_NN
sequence_NN
-LRB-_-LRB-
TGGAAATTCC_NN
-RRB-_-RRB-
._.

No_DT
glucocorticoid_NN
recognition_NN
sequences_NNS
are_VBP
present_JJ
in_IN
this_DT
promoter_NN
region_NN
and_CC
dexamethasone_NN
is_VBZ
still_RB
able_JJ
to_TO
repress_VB
transcription_NN
when_WRB
the_DT
multimerized_JJ
NF-kappa_NN
B_NN
sequence_NN
is_VBZ
transactivated_VBN
by_IN
TNF-alpha_NN
upon_IN
transfection_NN
in_IN
293_CD
cells_NNS
._.

We_PRP
propose_VBP
that_IN
direct_JJ
interaction_NN
between_IN
the_DT
glucocorticoid_NN
receptor_NN
and_CC
nuclear_JJ
factor-kappa_NN
B_NN
factors_NNS
is_VBZ
at_IN
least_JJS
a_DT
partial_JJ
explanation_NN
for_IN
the_DT
effects_NNS
of_IN
this_DT
hormone_NN
in_IN
inflammatory_JJ
diseases_NNS
._.

